INTRODUCTION T
ARGETED DELIVERY OF GENE(S) into cells in vivo is of major interest for advancing the role of gene therapy in the treatment of or restoration of function in damaged or diseased organs (Barker et al., 2003; Gregorevic and Chamberlain, 2003) . Cellular-based therapies using stem cells are being evaluated as possible treatment options for acute and chronic diseases such as stroke, myocardial infarction, liver diseases, and demyelinating/dysmyelinated disorders of central nervous systems (Orlic et al., 2001; Savitz et al., 2002 Savitz et al., , 2003 Fisher, 2003; Ishikawa et al., 2003; Korbling et al., 2003; Muraro et al., 2003; Orlic, 2003; Pluchino et al., 2003) . Autologous or allogenic stem cell transplantation or infusions are being used to regenerate tissues (Pedrazzoli et al., 2003; Wulffraat et al., 2003) . However, delivery of corrective gene-carrying cells or stem cells by simple intravenous injection is not possible because of lack of specific homing. Any process that delivers these cells at the specific site of interest after noninvasive intravenous administration would solve this problem.
Efficient methods for incorporation of superparamagnetic iron oxide (SPIO) nanoparticles into cells have been developed, providing the ability to monitor the migration of cells into tissues by magnetic resonance imaging (MRI; Bulte et al., 1999 Bulte et al., , 2001 Dodd et al., 2001; Frank et al., , 2003 Moore et al., 2002; Arbab et al., 2003a; Hinds et al., 2003; Kircher et al., 2003 , Kraitchman et al., 2003 . Labeling stem cells or other hematopoietic cells such as antigen-sensitized lymphocytes with SPIO nanoparticles does not alter the cells functional or metabolic capacity to differentiate or the cells' viability compared to unlabeled cells in vitro or in vivo (Dodd et al., 2001; Arbab et al., 2003a,b; Kircher et al., 2003) . Moreover, the temporal spatial migration of SPIO-labeled cells administered directly into normal and diseased tissue could be monitored by cellular MRI (Bulte et al., 1999 (Bulte et al., , 2001 . Ferumoxide is one of the SPIOs that are routinely used as a contrast agent for reticuloendothelial systems (Ferrucci and Stark, 1990) . The accumulation of ferumoxides within endosomes results in negative enhancement on MRI because of its magnetic susceptibility effect. Ferumoxides are superparamagnetic (i.e., magnetic only in the presence of a magnetic field) but when incorporated in cells, a strong magnet could exert enough force on the intracellular ferumoxides to move them and the host cells to a designated place.
The purpose of this pilot study was to determine if intravenously infused SPIO-labeled mesenchymal stem cells (MSCs) would be targeted by the application of an external magnetic field over the liver of rats, serving as a basis for a novel method of delivery of genetically altered cells or stem cells to targeted tissues or organs.
MATERIALS AND METHODS

Cell culture
Human MSCs (BioWhittaker, Walkersville, MD) grown in standard culture media at 37°C and 95% air/5% CO 2 were used for this study. MSCs were labeled with ferumoxide-poly-L-lysine (FE-PLL) complexes when they were near-confluent (usually 20,000 cells/cm 2 ) to the culture flasks.
Transfection of ferumoxides into MSCs
PLL (Sigma, St. Louis, MO, molecular weight, 388,100), a polyamine, was used as a transfection agent. Stock solution of PLL was prepared at 1-1.5 mg/ml. Ferumoxide (Feridex IV ® , Berlex Laboratories, Inc., Wayne, NJ) at a concentration of 50 mg/ml was put into a mixing flask or tube containing complete media and then PLL was added to the solution at 1.5 mg/ml. The FE to PLL ratio was 1:0.03 mg. Then the solution containing FE and PLL was allowed to mix in a rotator for 30-60 min. After 30-60 min, equal volume of the solution containing FE-PLL complexes was added to the existing media in the cell culture and kept overnight at 37°C in 95% air/5% CO 2 atmosphere. The final concentrations of FE-PLL would be in a ratio of FE to PLL of 25:0.75 mg/ml. After overnight incubation, MSCs were washed twice with sterile phosphate-buffered saline (PBS) and then incubated with media containing fluorescent dye DiI (5 ml/ml Vibrant DiI cell-labeling solution, Molecular Probe, Eugene, OR) for 15 min. Labeled cells were collected after washing twice with sterile PBS and trypsinization, and volume was adjusted for injection.
Magnetic properties of FE-PLL-labeled cells
After labeling with FE-PLL, washing twice with PBS, and trypsinization, rapidly growing FE-PLL-labeled HeLa cells (grown and labeled by standard methods; Arbab et al., 2003a) at density of 40,000/cm 2 were placed in pair of culture dishes (10-cm circular culture dish with 2-mm thick surfaces) and allowed to adhere to the bottom of the plate during incubation for a period of 24 hr. After incubation for 24 hr (after adherence of all cells), a 0.34-T circular (2.5-cm diameter) NbFeB magnet (Edmund Scientific, Tonawanda, NY) was placed under the center of one of the culture dishes for a period of 48 hr. The culture media was then removed and the cells were fixed. T2*-weighted images (see below for details of imaging) of the dishes were acquired with a 1.5-T clinical MRI system using a 5-inch circular general-purpose surface coil. Cells were stained with Perl's reagent (see below) and photomicrographs were obtained of the dishes at various magnifications to determine the distribution of FE-PLL-labeled HeLa in the dish under which the magnet was placed compared to a plate under which no magnet was placed. To determine the effect of magnet on unlabeled cells, HeLa cells were treated in the same manner as FE-PLL-labeled cells and an MRI was obtained. The entire experiment was repeated twice. HeLa cells were used because the cells are approximately the same size as MSCs and can be labeled with similar amounts of FE-PLL. MSCs stop growing once they reach confluence (confluence-inhibited). If cells do not divide, there might be difficulty in attracting completely adherent cells toward magnetic gradients. On the other hand, HeLa cells continue growing even after complete confluence, thereby daughter cells would not attach to the culture dish and could be attracted toward the magnetic field gradient.
Injection of magnetically labeled MSCs
All animal experiments were performed according to approved animal care and use committee protocol of our institute (Clinical Center, National Institutes of Health, Bethesda, MD). Approximately 800,000-1,000,000 FE-PLL-labeled MSCs were injected intravenously through tail veins in nude rats (Hrum, Poolsville, MD). Rats were paired and placed in matched groups (i.e., with external magnet [group 1] and without external magnet [group 2]) to ensure that pairs of animals received the same number of FE-PLL-labeled cells. In each batch, half of the rats wore custom-made jackets that held a small magnet (circular, 2.5 cm in diameter, NdFeB magnet 0.34 T) over the liver (Fig. 1 ) during intravenous injection of magnetically labeled MSCs and kept over the liver until a predetermined time of euthanization. Randomly selected pairs of rats (from group 1 and group 2) underwent serial MRI to determine the signal intensity (SI) changes of the liver on day 1, 8, 15, 22, and 29. After MRI, these rats were euthanized on day 29 and livers were collected to measure the iron concentration, immunohistochemistry on frozen sections, and for the qualitative presence of iron on histology by Prussian blue stain. All rats from both groups that were not imaged were euthanized on days 1, 8, 15, and 22 for collection of livers to measure the iron concentration by immunohistochemistry on frozen sections and for the qualitative presence of iron on histology by Prussian blue stain. For each time point at least 4 rats (usually 4-5 rats, with
FIG. 1.
A rat wearing jacket with a circular magnet placed over the liver.
or without jackets) were used for both imaging and collection of livers. To rule out the nonspecific iron accumulation resulting from the effect of magnets, control rats (n 5 5) were injected with unlabeled MSCs and an external magnet was placed over their livers. These animals were imaged serially and were euthanized on day 29. The control livers were handled and evaluated in similar method as animals from group 1 and 2. Table  1 shows the details of animal used for MRI, liver iron concentration, and histology.
Magnetic resonance tracking of labeled cells in the liver
Four pair of rats from group 1 and 2 had serial MRI performed on days 1, 8, 15, 22, and 29 after intravenous injection of magnetically labeled MSCs. T1-weighted (TR/TE 500/20 ms), T2-weighted (TR/TE 3000/90 ms), proton density (TR/TE 3000/45 ms), and T2*-weighted (TR/TE/flip angle 300/20/30) MRIs of the liver were obtained by a 1.5-T imager (Signa, GE, Milwaukee, WI) using a wrist coil. MRIs were obtained using fast spin echo (FSE) sequences with a matrix size of 256 3 160, 2 excitations, a slice thickness of 2 mm, and 6-8 cm field of view. The external magnet was removed just prior to MRI. There were some SI differences between the lobes of the liver. To minimize the biased measurement, essentially the whole liver area was covered with a contoured region of interest on each of 4-6 consecutive sections through almost the entire liver by an observer who was blinded to the animal's group assignment. The SI were averaged over the 4-6 slices. Identical axial images were selected in each rat. The average SI of each region of interest (ROI) was normalized to the SI of a phantom made of vitamin E oil placed parallel to the rat during image acquisition. SIs of the livers at each time point were expressed as percentage of average liver signal intensity of the rats from group 2 (without external magnet) on day 29.
Immunohistochemistry and Prussian blue staining
After euthanasia, livers were removed and 7-to 10-mm frozen sections were obtained for staining with anti-HLA-1 antibody labeled with a fluorescent marker (fluorescein isothiocyanate [FITC] , 525-nm wavelength) to detect the human MSCs in the liver. The HLA-1-positive cells were also subjected to analysis for the presence of dye DiI (570 nm wavelength) in the MSCs. Double-fluorescent (FITC and DiI) labeled cells detected in the liver were considered as MSCs. Digital photomicrographs (Axioplan II, Zeiss, Germany) under fluorescent conditions were obtained of the sections from rats at different times, and then either the same sections or adjacent sections were stained with Prussian blue to identify the cells containing iron particles. Prussian blue staining was also performed on the sections prepared from paraformaldehyde fixed and paraffin embedded liver sections (6-10 mm). Sections from paraffin embedded blocks were passed through standard deparaffinization and rehydration procedures. The glass slides containing either frozen or rehydrated paraformaldehyde-fixed paraffin embedded sections were put into Perl's reagent for 30 min at 60°C. After cooling, the slides were washed three times with PBS and put into hydrogen peroxide-activated diaminobenzide (DAB) solution for 5-10 min. After washing an additional three times with PBS, the sections were counterstained with either nuclear fast red or hematoxylin, washed, and coverslipped after dehydration procedures. Digital bright field photomicrographs were obtained at the same magnification to match the fluorescent images to confirm that the HLA-1-and DiI-positive cells contain iron particles.
Determination of number of MSC in the liver
To determine the number of accumulated MSCs in the liver, representative Prussian blue stained liver slides from group 1 and group 2 rats at each time point were selected. At least 5 fields of views (403 magnification) were selected randomly, photomicrographed, and then Prussian blue-stained cells were counted in each view manually with the investigator blinded as to which group the images were obtained from. An observer who was blinded to the experimental groups of the rats counted the number of Prussian blue-stained MSC cells in the livers in at least 5 high-powered fields focused primarily around portal triads.
Measurement of iron concentration in the liver
Three small pieces of liver each from left, right, and middle lobes (that were closer to the abdominal wall and external magnetic field), weighing between 0.1-0.2 g, were collected in nuclear magnetic resonance (NMR) tubes from all rats of group 1 and 2 rats on day 1, 8, 15, 22, and 29 and dried by an oven at 110°C overnight. The dried tissue was dissolved in 1 ml of a mixture of perchloric and nitric acids (3:1 ratio). The iron concentration in the solution was measured by NMR relaxometry and normalized to standard as described previously (Bulte et al., 2001; Frank et al., 2003; Arbab et al., 2003a,b) . Iron concentration of the livers at each time point was expressed as a percentage of average iron in the corresponding liver of the rats from group 2.
Statistical analysis
Data are expressed as mean 6 standard error of mean (SEM) and significant test was performed with analysis of variance (ANOVA). A p value less than 0.05 was considered significant difference.
RESULTS
FE-PLL-labeled HeLa cells in culture clearly migrated toward and around the margin of a magnet placed under the cul- ture dish. MRI of the culture dish showed a clear hypointense ring caused by the susceptibility of iron in endosomes directly above the area in which the external magnet was placed (Fig.  2) . Prussian blue staining of cells in a culture dish revealed a high concentration of labeled cells in the area near the edge of magnet ( Fig. 2C and 2D ) compared to samples from where no magnet was used ( Fig. 2E and 2F ). Unlabeled cells showed no migration toward the margin of the magnet. Figure 2G is a plot of the magnetic field gradient from the face (along the diameter) of the magnet. The field falls off exponentially as one moves away from the magnet and the field is higher near the margin of the magnet. Fifty percent of the gradient field can still be observed at a distance of 5 mm from the edge.
Representative T2*-weighted images of rat livers with or without administration of labeled MSCs and histochemical verification of injected MSCs in the liver are shown in Figure 3 . Liver signal intensity became hypointense after intravenous administration of FE-PLL-labeled MSCs, and the signal intensity gradually returned to that of control rat liver around day 29 (Fig. 3A-3D ). DAB-enhanced Prussian blue and corresponding HLA-1 staining (as well as DiI labeling) of serial consecutive section proved the presence of iron containing human cells ( Fig. 3E and 3F) . A paraffin-embedded section showed detailed architecture of liver tissues infiltrated with iron-containing MSCs (Fig. 3G) , which differs from a representative control rat liver with unlabeled MSCs (Fig. 3H ). MSCs were clearly different from sinusoidal cells (Kupffer cells) and there were no inflammatory cells or macrophages seen. Labeled MSCs contained an average of 10-15 pg of iron per cell determined by the methods described elsewhere (Arbab et al., 2003b) .
The percent SI changes over time for the rats with or without placement of an external magnet for various durations are shown in Figure 4 . SI changes were rapid in livers without jackets (group 2) and became significantly different after day 15 (Fig. 4A ) compared to rats wearing an external magnet (group 1). The corresponding iron concentration (percentage of iron concentration in corresponding rats without magnet) in the liver is shown in Figure 4B . Concentration of iron in liver was always significantly higher in rats with an external magnet in place (group 1).
Quantitative analysis of the number of MSCs (counted on 5 field of views) in the liver from both groups of rats at different times of euthanasia demonstrates a significant increase in number of labeled cells in group 1 rats compared to group 2 rats on days 15 and 22 (p , 0.05) (Fig. 5A) . In both groups of rats, labeled MSCs were predominately observed around the portal triad, but in the rats with an external magnet in place, labeled MSCs were also observed deep (i.e., away from portal triad) within the liver (Fig. 5B and 5C ).
DISCUSSION
Cells labeled with iron oxide nanoparticles have been successfully utilized to monitor the cell migration on MRI in various experimental disease models (Bulte et al., 1999 (Bulte et al., , 2001 Dodd et al., 2001; Hoehn et al., 2002; Anderson et al., 2002; Moore et al., 2002; Arbab et al., 2003a,b; Kircher et al., 2003) . Complexing polycationic transfection agents to ferumoxides allows for the incorporation of the SPIO into the endosomes of a variety of nonphagocytic, nondividing or phagocytic rapidly dividing cells. This magnetic labeling technique has been shown to have no short-or long-term toxic effects to cells (Arbab et al., 2003a,b) . The incorporation of FE into the endosomes results in the cell itself acting as a magnetic resonance superparamagnetic contrast agent, thereby magnifying the T2* shortening and the susceptibility effects of the SPIO contrast agent. In addition FE-labeled cells are attracted to magnets and therefore can be moved by a magnetic field gradient (Wilhelm et al., 2002) . By labeling MSCs with FE-PLL, these cells can then be separated from unlabeled cells using magnetic columns (magnetic activated cell sorter [MACS] ) that are used for cell sorting using antibody-labeled magnetic beads (Martin-Henao et al., 1996) . We have demonstrated that FE-PLL magnetically labeled cells can migrate to areas of high magnetic field gradients even after being plated and adhering to surface of culture dish for 24 hr (Fig. 2) . Considering the thickness of the culture dish, the magnetic field clearly showed effective gradient beyond 2-3 mm that could attract magnetically labeled cells. Moreover, measured gradient field showed only 50% loss of gradient at a distance of 5 mm from the edge of the magnet (Fig. 2G) , which indicates the effective gradient might be working at a distance from the surface of the magnet. Therefore, we hypothesized that with the application of a magnetic field gra- dient, FE-PLL-labeled cells could be targeted or directed to certain regions of the body after an intravenous injection in an animal model, thus facilitating the retention of these labeled cells in the targeted tissue for extended periods of time. By directing these magnetic labeled cells to areas of tissue damage, it may be possible to stimulate tissue repair or replacement of function by introducing cells into the host organs.
In the current study, we observed an increase in the number of magnetically labeled MSCs in the livers of rats that had external magnets in place over their livers compared to rats without external magnets. These results support our hypothesis that a magnetic field gradient may direct and aid in the retention of these SPIO-labeled cells within a region of interest. Previously, Wilhelm et al. (2002) developed a model related to movement of magnetically labeled cells towards external magnetic field. Using a technique known as magnetophoresis, these authors demonstrated the movement of SPIO-labeled cells in an external magnetic field and reported that the drag force on the cell depended on several factors including the concentration of iron in the cells, effective saturation of SPIO in cells, nanoparticle distribution in the cells, strength of external magnetic field, magnetic field gradient, cell size, and viscosity of the media. For SPIO labeled macrophages at about 8 pg of iron per cell, the reported cell velocities in the presence of an approximately 0.3-T magnet ranged from 18 to 40 mm/sec in culture media and experimental conditions (Wilhelm et al., 2002) . Organ blood flow and blood viscosity will also contribute to the effectiveness of an external magnetic field and its gradient field across the tissue and will influence the direction of movement and residence time of magnetically labeled cells in the volume of interest. By considering the blood flow through capillaries, concentration of incorporated iron in the cells, and distance of the organ from the magnet, it is possible to determine the optimum strength of the magnetic field gradients needed to retard the intravascular movement of the labeled cells in the target tissue, and ultimately, in combination with homing mechanisms, increase the numbers of intravenously or intra-arterially delivered cells.
Capillary red blood cell flow velocity in the normal rat liver is approximately 200 mm/sec (Tawadrous et al., 2002) . Based on an average concentration of 10-20 pg of iron per MSC, assumptions on cell size, particle density and blood viscosity, it is possible that the field gradient of the external magnet (Fig.  2 ) may have slowed down the transit of the labeled stem cells within the hepatic capillaries. The effect of the magnetic field was obvious in the current study, which resulted in an increase in FE-PLL-labeled cell numbers and iron concentration, and slower SI changes in rat liver on MRI that had external magnets in place for various lengths of time compared to other group of animals. Because the results for all sampled time points were not all significantly different between group 1 (with external magnets) and group 2 (without external magnets) (Fig. 4) , it is to be expected that injected cells would be distributed uniformly throughout the liver parenchyma during the first few passes in the circulation and therefore the initial accumulation of labeled MSCs would be similar for both groups. The magnetic field gradient could result in a more nonuniform distribution of cells at the edge of the magnet, although there is also a gradient field that originates perpendicular to the face of the magnet and would also contribute to the slowing of iron oxide-labeled cells. The small difference at day 1 might be caused by the increased retention of the recirculated cells after first-pass accumulation. The gradual widening of differences between the group 1 and group 2 might be the result of differential release of accumulated cells as well as accumulation of recirculated labeled cells. It is also possible that the lack of differences may be caused in part by biologic variability between animals, cell division and dilution of label, sampling error, mobilization of labeled cells from the liver or metabolism of iron within MSCs. The magnetic gradient field may not have covered a large enough area to cause a slowing of labeled cells such that would remain in the liver. Moreover, because we measured only the average iron concentration per cell, it is possible that assumptions made
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Day 29 about the alteration in the velocity or direction of the labeled cells may not apply to all cells and could possibly be overcome by increasing the amount of iron label per cell or by increasing the magnetic field gradient per cubic millimeter, which should result in a greater slowing of cells as they move through the liver especially if velocities or distances of magnet from chest/abdominal wall is increased. Long-term placement of a magnet or pulsed field gradients may be useful, especially if iron metabolism occurs, or if necessary homing cytokines are needed to draw cells out of bone marrow or other resident locations. The nonuniformity in the significant differences (in SI, iron and cell numbers) between two groups might be caused by selection of volume of tissues. The averaged SI was obtained from creating large irregular ROIs on 4-6 consecutive axial images, which represented a thickness of 8-12 mm of the liver. Practically, the ROIs covered more areas (thereby number of cells) in the liver than those covered by histology or liver iron concentration. The histology covered only randomly selected representative 5 sections of 6-10 mm liver (maximum 50 mm). For iron concentration measurement small pieces of liver were collected only from left, middle, and right lobes, which were closer to the magnet.
Magnetic resonance cell tracking studies have been able to follow cell migration after direct invasive administration of labeled cells into targets of interest (i.e., myocardium or brain) (Hoehn et al., 2002; Hill et al., 2003; Kraitchman et al., 2003) . In the current study, magnetically labeled cells were administered intravenously and were tracked using a clinical MRI (1.5-T) system resulting in a decrease in signal intensity of the liver on T2-and T2*-weighted images (Figs. 3 and 4) . The gradual increase in SI in the liver with time in both group 1 and 2 rats might be either due to the result of mobilization of labeled cells out of the liver, or dilution by cell division as well as utilization of iron in the normal iron metabolic pathway of the cells. It has already been shown that stem cells home to the liver soon after intravenous administration and gradual mobilization of cells out of the liver (Zanjani et al., 1992; Gao et al., 2001; Aicher et al., 2003) . Previously we have shown that after 5-8 cell divisions, FE-PLL-labeled cells are no longer detectable by MRI or on Prussian blue staining (Arbab et al., 2003b) . However, MSCs do not rapidly divide in vitro and therefore were not expected to undergo 5 divisions in the liver by day 29, which would have resulted in a dilution of the iron from the cells. The significantly different gradual increase of SI on days 15-29 might be caused by differential mobilization of cells out of livers.
Although we have not investigated whether the accumulated MSCs transform into hepatocytes, the morphology of the labeled MSCs was similar to hepatocytes and the MSCs became incorporated into the normal hepatic architecture. Also of note, there was no histologic evidence of iron being dislodged from FE-PLL-labeled cell in rats with external magnetic field gradient because the Kupffer cells in the area of the FE-PLL-labeled MSCs were Prussian blue-negative.
Magnetic localization of genetically engineered cells to a specific tissue may provide a method to enhance delivery of gene products for treatment or replacement therapy. This approach may be more appropriate in cases of intra-arterial administration of genetically altered or stem cells into the target organ or other tissues such as tumors. In an experimental model of reendothelialization of the luminal surface of balloon-dilated arteries using control and superparamagnetic microspheres containing endothelial cells, Consigny et al. (1999) have shown circumferential delivery of endothelial cells in the dilated lumen by an external magnet. In addition, Hafeli et al. (1995) have also reported increased (73% of total radioactivity) accumulation of intraperitoneally administered magnetic biodegradable poly (lactic acid) microspheres that incorporate both magnetite and the beta-emitter 90Y in a murine subcutaneous tumor model that had a magnet fixed over the tumor, whereas tumor without a magnet showed only 6% of total radioactivity. Recently Wilson et al. (2004) utilized 5 kG external magnetic field to deliver and localize the iron-labeled chemotherapeutic agents in hepatocellular carcinoma by intra-arterial injection. The aim of this experiment was to validate cell tracking at 1.5 T, which is clinically relevant field strength and has commonly available pulse sequences. As our results indicate, it may be possible to detect the effect of an external magnetic field gradient on labeled cells in the liver and therefore in the future it may be possible to introduce these methods into clinical trials.
In conclusion, this is the first time that MRI has been used to monitor magnetic delivery of stem cells labeled with iron oxides. With the addition of magnetic field gradients, SPIO-labeled cells can be delivered and retained at a site of interest and should open a new era of delivering stem cells or gene to target tissues for treatment, repair, or replacement strategies.
